Mark J. Cayabyab

2.8k total citations · 1 hit paper
31 papers, 2.5k citations indexed

About

Mark J. Cayabyab is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Mark J. Cayabyab has authored 31 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 14 papers in Infectious Diseases and 13 papers in Virology. Recurrent topics in Mark J. Cayabyab's work include Immune Cell Function and Interaction (15 papers), HIV Research and Treatment (13 papers) and Immunotherapy and Immune Responses (11 papers). Mark J. Cayabyab is often cited by papers focused on Immune Cell Function and Interaction (15 papers), HIV Research and Treatment (13 papers) and Immunotherapy and Immune Responses (11 papers). Mark J. Cayabyab collaborates with scholars based in United States, France and Netherlands. Mark J. Cayabyab's co-authors include Lewis L. Lanier, Joseph H. Phillips, Joseph Sodroski, Michael Farzan, Miyuki Azuma, Hyeryun Choe, David Buck, Peter Kolchinsky, Tajib A. Mirzabekov and Norma P. Gerard and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Mark J. Cayabyab

30 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry

1999 577 citations Michael Farzan, Tajib A. Mirzabekov et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Cayabyab United States	18	1.6k	994	579	542	388	31	2.5k
Gregory Roderiquez United States	20	917 0.6×	823 0.8×	509 0.9×	346 0.6×	563 1.5×	25	1.9k
George J. Leslie United States	20	1.2k 0.8×	923 0.9×	599 1.0×	576 1.1×	192 0.5×	27	2.5k
Gregory A. Viglianti United States	24	1.9k 1.2×	550 0.6×	813 1.4×	287 0.5×	253 0.7×	42	3.0k
Fabrizio Poccia Italy	37	3.1k 2.0×	623 0.6×	532 0.9×	541 1.0×	677 1.7×	92	4.3k
Jean Edouard Gairin France	25	2.0k 1.3×	897 0.9×	1.0k 1.7×	456 0.8×	440 1.1×	61	3.2k
Andrew J. Henderson United States	29	1.1k 0.7×	1.1k 1.1×	855 1.5×	592 1.1×	193 0.5×	73	2.4k
Mark Kowalski United States	21	829 0.5×	1.5k 1.5×	991 1.7×	876 1.6×	213 0.5×	50	2.8k
Fiorenza Cocchi United States	15	2.1k 1.4×	2.4k 2.4×	494 0.9×	798 1.5×	449 1.2×	26	3.4k
Bernard Maillère France	34	1.8k 1.1×	207 0.2×	1.2k 2.0×	183 0.3×	601 1.5×	141	3.7k
Joel M. Depper United States	11	1.8k 1.2×	475 0.5×	419 0.7×	237 0.4×	386 1.0×	14	2.6k

Countries citing papers authored by Mark J. Cayabyab

Since Specialization

Citations

This map shows the geographic impact of Mark J. Cayabyab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Cayabyab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Cayabyab more than expected).

Fields of papers citing papers by Mark J. Cayabyab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Cayabyab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Cayabyab. The network helps show where Mark J. Cayabyab may publish in the future.

Co-authorship network of co-authors of Mark J. Cayabyab

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Cayabyab. A scholar is included among the top collaborators of Mark J. Cayabyab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Cayabyab. Mark J. Cayabyab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shindo, Satoru, Sibel A. Antonson, Frank C. Nichols, et al.. (2024). Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome. Microbiology Spectrum. 12(10). e0059924–e0059924. 3 indexed citations

Antonson, Sibel A., et al.. (2022). Assessment of SARS‐CoV‐2 entry in gingival epithelial cells expressing CD147. European Journal Of Oral Sciences. 131(1). e12906–e12906. 1 indexed citations

Cayabyab, Mark J., et al.. (2020). A Systematic Approach to HIV-1 Vaccine Immunogen Selection. AIDS Research and Human Retroviruses. 36(9). 762–770. 7 indexed citations

Duncan, Margaret J., et al.. (2015). Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance. PLoS ONE. 10(11). e0143422–e0143422. 7 indexed citations

Daifalla, Nada, Mark J. Cayabyab, Hyeun Bum Kim, et al.. (2014). Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination. Microbes and Infection. 17(3). 237–242. 13 indexed citations

Cayabyab, Mark J., et al.. (2013). An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection. Vaccine. 31(42). 4834–4840. 5 indexed citations

Cayabyab, Mark J., Lilia Macovei, & Antonio Campos‐Neto. (2012). Current and novel approaches to vaccine development against tuberculosis. Frontiers in Cellular and Infection Microbiology. 2. 154–154. 23 indexed citations

Cayabyab, Mark J., Suely Sanae Kashino, & Antonio Campos‐Neto. (2011). Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol. Immunology. 135(3). 216–225. 15 indexed citations

Hovav, Avi‐Hai, Michael W. Panas, Shaila Rahman, et al.. (2007). Duration of Antigen Expression In Vivo following DNA Immunization Modifies the Magnitude, Contraction, and Secondary Responses of CD8+ T Lymphocytes. The Journal of Immunology. 179(10). 6725–6733. 35 indexed citations

10.

Hovav, Avi‐Hai, Michael W. Panas, Christa E. Osuna, et al.. (2007). The Impact of a Boosting Immunogen on the Differentiation of Secondary Memory CD8 ⁺ T Cells. Journal of Virology. 81(23). 12793–12802. 27 indexed citations

11.

Cayabyab, Mark J., Georgios Pollakis, Almaz Abebe, et al.. (2004). Rapid CD4+ T-Lymphocyte Depletion in Rhesus Monkeys Infected with a Simian–Human Immunodeficiency Virus Expressing the Envelope Glycoproteins of a Primary Dual-Tropic Ethiopian Clade C HIV Type 1 Isolate. AIDS Research and Human Retroviruses. 20(1). 27–40. 17 indexed citations

12.

Song, Byeongwoon, Mark J. Cayabyab, Ngoc Phan, et al.. (2004). Neutralization sensitivity of a simian–human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease. Virology. 322(1). 168–181. 10 indexed citations

13.

Si, Zhihai, Paul R. Gorry, Christopher M. Owens, et al.. (2004). Envelope Glycoprotein Determinants of Increased Entry in a Pathogenic Simian–Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Passaged in Monkeys. AIDS Research and Human Retroviruses. 20(2). 163–173. 15 indexed citations

14.

Zhou, Naiming, Zhaowen Luo, Jiansong Luo, et al.. (2002). Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from Chemokines. Journal of Biological Chemistry. 277(20). 17476–17485. 107 indexed citations

15.

Si, Zhihai, Mark J. Cayabyab, & Joseph Sodroski. (2001). Envelope Glycoprotein Determinants of Neutralization Resistance in a Simian-Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Derived by Passage in Monkeys. Journal of Virology. 75(9). 4208–4218. 54 indexed citations

16.

Cayabyab, Mark J., Shuji Hinuma, Michael Farzan, et al.. (2000). Apelin, the Natural Ligand of the Orphan Seven-Transmembrane Receptor APJ, Inhibits Human Immunodeficiency Virus Type 1 Entry. Journal of Virology. 74(24). 11972–11976. 72 indexed citations

17.

Kolchinsky, Peter, Tajib A. Mirzabekov, Michael Farzan, et al.. (1999). Adaptation of a CCR5-Using, Primary Human Immunodeficiency Virus Type 1 Isolate for CD4-Independent Replication. Journal of Virology. 73(10). 8120–8126. 142 indexed citations

18.

Farzan, Michael, Tajib A. Mirzabekov, Peter Kolchinsky, et al.. (1999). Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry. Cell. 96(5). 667–676. 577 indexed citations breakdown →

19.

Cayabyab, Mark J., Joseph H. Phillips, & Lewis L. Lanier. (1994). CD40 preferentially costimulates activation of CD4+ T lymphocytes.. The Journal of Immunology. 152(4). 1523–1531. 204 indexed citations

20.

Azuma, Miyuki, Mark J. Cayabyab, David Buck, Joseph H. Phillips, & Lewis L. Lanier. (1992). CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.. The Journal of Experimental Medicine. 175(2). 353–360. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact